Hemorrhage - subarachnoid

The goals of treatment are to save your life, repair the cause of bleeding, relieve symptoms, and prevent complications such as permanent brain damage (stroke).

If the hemorrhage is due to an injury, surgery is done only to remove large collections of blood or to relieve pressure on the brain.

If the hemorrhage is due to the rupture of an aneurysm, surgery is needed to repair the aneurym. If the patient is critically ill, surgery may have to wait until the person is more stable. Surgery may involve a craniotomy (cutting a hole in the skull) and aneurysm clipping, which closes the aneurysm, or endovascular coiling, a procedure in which coils are placed within the aneurysm to reduce the risk of further bleeding.

If no aneurysm is found, the person should be closely watched by a health care team and may need repeated imaging tests.

Treatment for coma or decreased alertness status may be needed. This may include special positioning, life support, and methods to protect the airway. A draining tube may be placed into the brain to relieve pressure.

If the person is conscious, strict bed rest may be advised. The person will be told to avoid activites that can increase pressure inside the head. Such activities include bending over, straining, and suddenly changing position. The doctor may prescribe stool softeners or laxatives to prevent straining during bowel movements.

Blood pressure will be strictly controlled. This requires medicines given through an IV line. The medicine often requires frequent adjustments. A medicine called calcium channel blocker is used to prevent blood vessel spams.

Pain killers and anti-anxiety medications may be used to relieve headache and reduce intracranial pressure. Phenytoin or other medications may be used to prevent or treat seizures.

• < Page
1 2
• >

Previous Section

Subarachnoid hemorrhage Symptoms

Next Section

Subarachnoid hemorrhage Prevention

Review Date: 03/26/2009
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Daniel B. Hoch, PhD, MD, Assistant Professor of Neurology, Harvard Medical School, Department of Neurology, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)